Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator (ICD) (SHIELD-2)

NCT ID: NCT01464476

Last Updated: 2013-05-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE3

Total Enrollment

240 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-11-30

Study Completion Date

2013-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will evaluate the efficacy and safety of Azimilide on the incidence of cardiovascular hospitalizations, cardiovascular emergency department visits or cardiovascular death in patients with Implantable Cardioverter Defibrillators (ICDs)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Arrhythmias, Cardiac Heart Diseases Cardiovascular Diseases Implantable Cardioverter Defibrillator

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Azimilide

Azimilide 75 mg film coated tablets

Group Type EXPERIMENTAL

Azimilide Dihydrochloride

Intervention Type DRUG

Azimilide 75 mg. Once daily, oral administration

Placebo

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Dose-matched placebo. Once daily, oral administration

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Azimilide Dihydrochloride

Azimilide 75 mg. Once daily, oral administration

Intervention Type DRUG

Placebo

Dose-matched placebo. Once daily, oral administration

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Have an ICD implanted and a history of ventricular tachycardia, ventricular fibrillation, or an appropriate ICD therapy.
* Have a left ventricular ejection fraction \<= 0.40

Exclusion Criteria

* Have New York Heart Association (NYHA) Class IV Congestive Heart Failure (CHF) or have decompensated CHF at the time of randomization;
* Have unstable angina pectoris or a myocardial infarction within 30 days of randomization;
* Have a history of Torsade de Pointes or heart transplantation
* Have chronic atrial fibrillation or atrial fibrillation/flutter, that is not adequately rate controlled in the judgment of the Investigator, at screening;
* Are currently taking systemic Class I or other Class III antiarrhythmic drugs
* Are currently taking systemic drugs that prolong the QT interval
* If female, are currently pregnant or breast feeding, or plan to become pregnant during the course of the study
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Forest Laboratories

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

David B Bharucha, MD, PhD

Role: STUDY_DIRECTOR

Forest Laboratories

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Forest Investigative Site 053

Birmingham, Alabama, United States

Site Status

Forest Investigative Site 048

Huntsville, Alabama, United States

Site Status

Forest Investigative Site 013

Phoenix, Arizona, United States

Site Status

Forest Investigative Site 110

Los Angeles, California, United States

Site Status

Forest Investigative Site 022

Merced, California, United States

Site Status

Forest Investigative Site 060

Colorado Springs, Colorado, United States

Site Status

Forest Investigative Site 090

Littleton, Colorado, United States

Site Status

Forest Investigative Site 041

Newark, Delaware, United States

Site Status

Forest Investigative Site 113

Hollywood, Florida, United States

Site Status

Forest Investigative Site 010

Jacksonville, Florida, United States

Site Status

Forest Investigative Site 035

Lakeland, Florida, United States

Site Status

Forest Investigative Site 044

Port Charlotte, Florida, United States

Site Status

Forest Investigative Site 062

Rockledge, Florida, United States

Site Status

Forest Investigative Site 082

Safety Harbor, Florida, United States

Site Status

Forest Investigative Site 006

Zephyrhills, Florida, United States

Site Status

Forest Investigative Site 123

Augusta, Georgia, United States

Site Status

Forest Investigative Site 092

Boise, Idaho, United States

Site Status

Forest Investigative Site 012

Bloomington, Indiana, United States

Site Status

Forest Investigative Site 068

Indianapolis, Indiana, United States

Site Status

Forest Investigative Site 087

South Bend, Indiana, United States

Site Status

Forest Investigative Site 063

Houma, Louisiana, United States

Site Status

Forest Investigative Site 050

Auburn, Maine, United States

Site Status

Forest Investigative Site 030

Baltimore, Maryland, United States

Site Status

Forest Investigative Site 058

Baltimore, Maryland, United States

Site Status

Forest Investigative Site 052

Lanham, Maryland, United States

Site Status

Forest Investigative Site 118

Silver Spring, Maryland, United States

Site Status

Forest Investigative Site 015

Boston, Massachusetts, United States

Site Status

Forest Investigative Site 091

Brighton, Massachusetts, United States

Site Status

Forest Investigative Site 020

Saginaw, Michigan, United States

Site Status

Forest Investigative Site 085

Southfield, Michigan, United States

Site Status

Forest Investigative Site 079

Troy, Michigan, United States

Site Status

Forest Investigative Site 034

Ypsilanti, Michigan, United States

Site Status

Forest Investigative Site 121

Tupelo, Mississippi, United States

Site Status

Forest Investigative Site 088

St Louis, Missouri, United States

Site Status

Forest Investigative Site 100

St Louis, Missouri, United States

Site Status

Forest Investigative Site 055

Englewood, New Jersey, United States

Site Status

Forest Investigative Site 059

Ridgewood, New Jersey, United States

Site Status

Forest Investigative Site 106

Warren Township, New Jersey, United States

Site Status

Forest Investigative Site 112

Albuquerque, New Mexico, United States

Site Status

Forest Investigative Site 018

Albany, New York, United States

Site Status

Forest Investigative Site 069

Albany, New York, United States

Site Status

Forest Investigative Site 045

New York, New York, United States

Site Status

Forest Investigative Site 122

New York, New York, United States

Site Status

Forest Investigative Site 075

Williamsville, New York, United States

Site Status

Forest Investigative Site 089

Chapel Hill, North Carolina, United States

Site Status

Forest Investigative Site 116

Greensboro, North Carolina, United States

Site Status

Forest Investigative Site 070

Canton, Ohio, United States

Site Status

Forest Investigative Site 064

Cincinnati, Ohio, United States

Site Status

Forest Investigative Site 124

Cincinnati, Ohio, United States

Site Status

Forest Investigative Site 043

Columbus, Ohio, United States

Site Status

Forest Investigative Site 083

Kettering, Ohio, United States

Site Status

Forest Investigative Site 109

Toledo, Ohio, United States

Site Status

Forest Investigative Site 119

Oklahoma City, Oklahoma, United States

Site Status

Forest Investigative Site 003

Tulsa, Oklahoma, United States

Site Status

Forest Investigative Site 056

Camp Hill, Pennsylvania, United States

Site Status

Forest Investigative Site 081

Erie, Pennsylvania, United States

Site Status

Forest Investigative Site 008

Erie, Pennsylvania, United States

Site Status

Forest Investigative Site 024

Hershey, Pennsylvania, United States

Site Status

Forest Investigative Site 095

Philadelphia, Pennsylvania, United States

Site Status

Forest Investigative Site 005

Wilkes-Barre, Pennsylvania, United States

Site Status

Forest Investigative Site 107

Yardley, Pennsylvania, United States

Site Status

Forest Investigative Site 046

York, Pennsylvania, United States

Site Status

Forest Investigative Site 084

Providence, Rhode Island, United States

Site Status

Forest Investigative Site 066

Florence, South Carolina, United States

Site Status

Forest Investigative Site 073

Greenville, South Carolina, United States

Site Status

Forest Investigative Site 014

Rapid City, South Dakota, United States

Site Status

Forest Investigative Site 094

Sioux Falls, South Dakota, United States

Site Status

Forest Investigative Site 029

Corpus Christi, Texas, United States

Site Status

Forest Investigative Site 028

Dallas, Texas, United States

Site Status

Forest Investigative Site 007

Fort Worth, Texas, United States

Site Status

Forest Investigative Site 111

Fort Worth, Texas, United States

Site Status

Forest Investigative Site 125

Houston, Texas, United States

Site Status

Forest Investigative Site 076

Houston, Texas, United States

Site Status

Forest Investigative Site 074

San Antonio, Texas, United States

Site Status

Forest Investigative Site 016

Chesapeake, Virginia, United States

Site Status

Forest Investigative Site 004

Falls Church, Virginia, United States

Site Status

Forest Investigative Site 117

Lynchburg, Virginia, United States

Site Status

Forest Investigative Site 065

Newport News, Virginia, United States

Site Status

Forest Investigative Site 072

Richmond, Virginia, United States

Site Status

Forest Investigative Site 023

Roanoke, Virginia, United States

Site Status

Forest Investigative Site 071

Green Bay, Wisconsin, United States

Site Status

Forest Investigative Site 042

Madison, Wisconsin, United States

Site Status

Forest Investigative Site 049

Milwaukee, Wisconsin, United States

Site Status

Forest Investigative Site 302

Bruges, , Belgium

Site Status

Forest Investigative Site 303

Charleroi, , Belgium

Site Status

Forest Investigative Site 300

Leuven, , Belgium

Site Status

Forest Investigative Site 304

Liège, , Belgium

Site Status

Forest Investigative Site 301

Yvoir, , Belgium

Site Status

Forest Investigative Site 264

Edmonton, Alberta, Canada

Site Status

Forest Investigative Site 269

Vancouver, British Columbia, Canada

Site Status

Forest Investigative Site 252

Victoria, British Columbia, Canada

Site Status

Forest Investigative Site 267

Hamilton, Ontario, Canada

Site Status

Forest Investigative Site 253

Kingston, Ontario, Canada

Site Status

Forest Investigative Site 259

Toronto, Ontario, Canada

Site Status

Forest Investigative Site 263

Toronto, Ontario, Canada

Site Status

Forest Investigative Site 254

Montreal, Quebec, Canada

Site Status

Forest Investigative Site 250

Montreal, Quebec, Canada

Site Status

Forest Investigative Site 270

Sherbrooke, Quebec, Canada

Site Status

Forest Investigative Site 262

Saskatoon, Saskatchewan, Canada

Site Status

Forest Investigative Site 750

Brno, , Czechia

Site Status

Forest Investigative Site 753

České Budějovice, , Czechia

Site Status

Forest Investigative Site 751

Olomouc, , Czechia

Site Status

Forest Investigative Site 754

Prague, , Czechia

Site Status

Forest Investigative Site 752

Sokolska, , Czechia

Site Status

Forest Investigative Site 852

Aalborg, , Denmark

Site Status

Forest Investigative Site 850

Copenhagen, , Denmark

Site Status

Forest Investigative Site 854

Esbjerg, , Denmark

Site Status

Forest Investigative Site 853

Hellerup, , Denmark

Site Status

Forest Investigative Site 851

Odense, , Denmark

Site Status

Forest Investigative Site 353

Grenoble, , France

Site Status

Forest Investigative Site 354

Lille, , France

Site Status

Forest Investigative Site 350

Montpellier, , France

Site Status

Forest Investigative Site 358

Nantes, , France

Site Status

Forest Investigative Site 357

Pessac, , France

Site Status

Forest Investigative Site 405

Berlin, , Germany

Site Status

Forest Investigative Site 402

Göttingen, , Germany

Site Status

Forest Investigative Site 410

Heidelberg, , Germany

Site Status

Forest Investigative Site 406

Ludwigshafen, , Germany

Site Status

Forest Investigative Site 401

Mannheim, , Germany

Site Status

Forest Investigative Site 450

Ashkelon, , Israel

Site Status

Forest Investigative Site 453

Jerusalem, , Israel

Site Status

Forest Investigative Site 452

Tel Aviv, , Israel

Site Status

Forest Investigative Site 451

Tel Litwinsky, , Israel

Site Status

Forest Investigative Site 504

Ancona, , Italy

Site Status

Forest Investigative Site 502

Catania, , Italy

Site Status

Forest Investigative Site 552

Breda, , Netherlands

Site Status

Forest Investigative Site 550

Eindhoven, , Netherlands

Site Status

Forest Investigative Site 555

Zwolle, , Netherlands

Site Status

Forest Investigative Site 706

Gdansk, , Poland

Site Status

Forest Investigative Site 705

Gdynia, , Poland

Site Status

Forest Investigative Site 604

Barcelona, , Spain

Site Status

Forest Investigative Site 601

Málaga, , Spain

Site Status

Forest Investigative Site 800

Lund, , Sweden

Site Status

Forest Investigative Site 805

Örebro, , Sweden

Site Status

Forest Investigative Site 804

Stockholm, , Sweden

Site Status

Forest Investigative Site 802

Stockholm, , Sweden

Site Status

Forest Investigative Site 801

Uppsala, , Sweden

Site Status

Forest Investigative Site 803

Västerås, , Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Belgium Canada Czechia Denmark France Germany Israel Italy Netherlands Poland Spain Sweden

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AZM-MD-302

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Study of AG10 in Amyloid Cardiomyopathy
NCT03458130 COMPLETED PHASE2
Effects of Triiodothyronine (T3) in Ischemic Heart Failure
NCT05384847 ACTIVE_NOT_RECRUITING PHASE1/PHASE2